Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Current Topics in Medicinal Chemistry|September 28, 2007
Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1-R) antagonistsRobert J DeVitaJournal of Medicinal Chemistry|August 8, 2013
Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitorsRobert J DeVita, Shirly PintoOrganic Letters|October 24, 2003
Synthesis of 4-trifluoromethylated 2-alkyl- and 2,3-dialkyl-substituted azetidinesJinlong Jiang, Hemal Shah, Robert J DeVitaThe Journal of Biological Chemistry|February 14, 2024
Monoubiquitination empowers ubiquitin chain elongationKenneth Wu, Robert J DeVita, Zhen-Qiang PanThe Journal of Biological Chemistry|February 14, 2024
Modulation of Cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compoundsKenneth Wu, Robert J DeVita, Zhen-Qiang PanCell Chemical Biology|January 19, 2019
Encounter and React: Computer-Guided Design of Covalent InhibitorsPeter Man-Un Ung, Robert J DeVita, Avner SchlessingerJournal of Cellular Signaling|October 4, 2021
Targeting Cullin-RING E3 Ubiquitin Ligase 4 by Small Molecule ModulatorsKenneth Wu, Benjamin D Hopkins, Roberto Sanchez, et al.Journal of Medicinal Chemistry|July 31, 2018
Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell ProliferationKunal Kumar, Peng Wang, Roberto Sanchez, et al.Journal of Medicinal Chemistry|March 8, 2021
DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for DiabetesKunal Kumar, Chalada Suebsuwong, Peng Wang, et al.Journal of Inherited Metabolic Disease|June 23, 2020
Deletion of 2-aminoadipic semialdehyde synthase limits metabolite accumulation in cell and mouse models for glutaric aciduria type 1João Leandro, Tetyana Dodatko, Robert J DeVita, et al.Pageof 7